Compounds > sr141716
Page last updated: 2024-08-26

sr141716 and incretins

sr141716 has been researched along with incretins in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Debaty, I; Halimi, S; Muller, M; Villaret, L1
Davies, MJ; Jarvis, J; Khunti, K; Srinivasan, BT1
Kautzky-Willer, A; Lemmens-Gruber, R1
Baretić, M1
Blumen, T; Brake, R; Cohen, Y; Ferreira, S; Kolodziej, A; Morningstar, M1

Reviews

4 review(s) available for sr141716 and incretins

ArticleYear
[New therapies for type 2 diabetes: what place for incretin-based agents and rimonabant compared to the previous ones?].
    La Revue de medecine interne, 2008, Volume: 29, Issue:11

    Topics: Administration, Oral; Diabetes Mellitus, Type 2; Glucagon; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Metabolic Syndrome; Metformin; Piperidines; Pyrazoles; Rimonabant; Safety; Sulfonylurea Compounds; Thiazolidinediones

2008
Recent advances in the management of type 2 diabetes mellitus: a review.
    Postgraduate medical journal, 2008, Volume: 84, Issue:996

    Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Hypoglycemic Agents; Incretins; Piperidines; Pyrazoles; Rimonabant

2008
Obesity and diabetes.
    Handbook of experimental pharmacology, 2012, Issue:214

    Topics: Animals; Cyclobutanes; Diabetes Mellitus; Female; Humans; Incretins; Insulin; Lactones; Male; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Sex Characteristics; Sulfonylurea Compounds

2012
Obesity drug therapy.
    Minerva endocrinologica, 2013, Volume: 38, Issue:3

    Topics: Anti-Obesity Agents; Appetite; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; Cyclobutanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Combinations; Exercise Therapy; Fructose; Gastrointestinal Hormones; Humans; Incretins; Insulin; Insulin Secretion; Intestines; Lactones; Leptin; Life Style; Models, Biological; Neuropeptides; Obesity; Orlistat; Phentermine; Phytotherapy; Piperidines; Plant Preparations; Pyrazoles; Rimonabant; Topiramate

2013

Other Studies

1 other study(ies) available for sr141716 and incretins

ArticleYear
Novel cannabinoid receptor 1 inverse agonist CRB-913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet-induced obesity mouse model.
    Obesity (Silver Spring, Md.), 2023, Volume: 31, Issue:11

    Topics: Animals; Body Weight; Diet; Drug Inverse Agonism; Incretins; Liraglutide; Mice; Obesity; Receptors, Cannabinoid; Rimonabant; Weight Loss

2023